目的探讨更适合晚期肝硬化患者输液渗漏的应对措施。
Objective Drug leakage is a common adverse effect of intravenous transfusion in patient with advanced liver cirrhosis.
结论自体干细胞移植治疗晚期肝硬化是一种安全、有效的治疗方法。
Conclusion Autologous stem cells transplantation might be a safe and effective method for decompensate liver cirrhosis.
慢性肝损伤的临床表现可以是轻微的炎症重到晚期肝硬化，程度不等。
The clinical spectrum of chronic liver injury ranges from mild inflammation to end stage liver cirrhosis.
结果：全组治愈25例(89.3%)另3例因胆管血管瘘和晚期肝硬化死亡。
Results 25 of all cases (89.3%) were cured. 3 cases died because of bile-vessel fistulas and advanced hepatocirrhosis.
本文对大肠杆菌内毒素(LPS)在实验性早期和晚期肝硬化中的致病作用进行了研究。
The effect of E. coli endotoxin (LPS) on early and advanced experimental cirrhosis have been studied.
IMA并不单单存在于心肌缺血的患者，它在肝硬化，急性传染病和晚期癌症患者身上也呈现高浓度——这些疾病都能生产大量自由基。
IMA is not specific for cardiac ischemia. IMA is also elevated in most patients with liver cirrhosis, acute infections and advanced cancers; all these conditions are potent producers of free radicals.
HBV通常可以逃避早期和晚期免疫应答导致慢性肝脏疾病——慢性乙型肝炎、乙肝后肝硬化、肝衰竭、肝癌。
HBV can usually escape early and late immune response leading to chronic liver disease-chronic hepatitis B, liver cirrhosis, liver failure and hepatic cellular carcinoma.
自发性细菌性腹膜炎（SBP），是肝硬化晚期患者一种严重的并发症，这被归因于肠道细菌的移位。
Spontaneous bacterial peritonitis (SBP), a severe complication in patients with advanced liver cirrhosis, has been attributed to bacterial translocation from the intestine.
结果预防组肝硬化病变程度轻，晚期治疗组病变程度介于模型组和预防组之间。
RESULTS The pathological process of liver in preventive group and late treatment group were improved.
结果预防组肝硬化病变程度轻，晚期治疗组病变程度介于模型组和预防组之间。
RESULTS The pathological process of liver in preventive group and late treatment group were improved.
应用推荐